Allurion Technologies, Inc. Common Stock ALUR 深 滬
已收盤 12-05 16:00:00 美东时间
1.70
-0.010
-0.58%
華盛通- 最 高1.75
- 今 開1.75
- 成交量 5.37万股
- 最 低 1.62
- 昨 收 1.71
- 總市值 460.91万
- 52周最高 16.81
- 市盈率 靜 --
- 換手率 1.98%
- 52周最低 1.02
- 委 比 78.57%
- 總股本 271.13万
- 歷史最高 225.00
- 量 比 0.71
- 振 幅 7.60%
- 歷史最低 1.62
- 每 手 1
- 風險率 2.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Allurion Technologies Reports Initial Results On Combination Of Allurion Program With Low-Dose Tirzepatide Therapy To Optimize Muscle Mass And GLP-1 Adherence
Average Total Weight Loss of 23% With 14% Increase in Lean Body Mass After 12 MonthsAll patients remained adherent to tirzepatide for the duration of the studyAllurion Technologies, Inc. ("Allurion" or the "Company")
11-25 22:28
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
11-21 15:50
Allurion Technologies Announces Strategic Distribution Partnership With ProSurg Medical To Establish New Standard Of Care Focused On Metabolically Healthy Weight Loss
Allurion Technologies, Inc. (NYSE:ALUR), a pioneer in metabolically healthy weight loss, today announced a strategic distribution partnership with ProSurg Medical, a leading Brazilian medical device company specializing
11-18 22:09
Allurion Technologies Q3 Adj. EPS $(1.18) Misses $(1.17) Estimate, Sales $2.658M Beat $2.350M Estimate
Allurion Technologies (NYSE:ALUR) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(1.17) by 0.6 percent. This is a 66.29 percent increase over losses of $(3.50) per share
11-12 21:03
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
A Look at Allurion Technologies's Upcoming Earnings Report
Allurion Technologies (NYSE:ALUR) is preparing to release its quarterly earning...
11-12 03:04
Allurion Technologies Passes Critical Milestones In U.S. FDA's Pre-Market Approval Process For Allurion Smart Capsule; Company To Exchange All Outstanding Debt, Obligations For Shares Of Newly Created Series B Convertible Preferred Stock
Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a pioneer in metabolically healthy weight loss, today announced it has passed critical milestones in the U.S. Food and Drug Administration (the
11-11 21:51
Allurion Highlights Peer-Reviewed Publication On Consecutive Use Of Allurion Smart Capsule
Multicenter study across six countries demonstrates safety and efficacy of two consecutive treatments in adults with obesityWeight loss of greater than 20% on par with bariatric surgery and high dose GLP-1 therapy
10-07 20:09
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Gainers Mixed Martial Arts Group (AMEX:MMA) shares moved upwards by 26.4% to $...
08-21 01:06
Allurion Technologies Shifts Strategy Amid Q2 Earnings
Allurion Technologies, Inc. ( ($ALUR) ) has released its Q2 earnings. Here is a...
08-14 12:32
